For the benefit of its customers, Protagen Protein Services (PPS) cultivates strategic partnerships with companies and research institutes. Beyond an intensive know-how exchange, PPS actively develops technologies that are ready for commercial applications. Please find a shortened list below:

Strategic Partners

Vela pharmazeutische Entwicklung und Laboranalytik GmbH, Vienna, Austria
Charles River Biopharmaceutical Services, US, Germany, Ireland, Scotland

Commercial Partners 

zelle biotechnology logo  Zelle Biotechnology, Mumbai, India
 logo tsdyne TS DYNE Co., Ltd., Seoul, South Korea
 logo cambridge bioscience Cambridge Bioscience Limited, Cambridge, United Kingdom

 

Protagen Protein Services is actively involved in the following academic projects:

MABTOX  (Development of novel enzymatically conjugated antibody drug conjugates (ADCs) for the better therapy of cancer, NBE therapeutics,Switzerland)

 

Protagen Protein Services is member of:

DECHEMA
Bio Deutschand
GFID (Gesellschaft zur Förderung der Immundiagnostik)
CLIB2021 - Cluster for Industrial Biotechnology
EAPB